[1] 孟昭君,牛春生,刘春苗. 200例外耳道炎病原菌的培养与耐药性分析[J].中国耳鼻咽喉头颈外科, 2019, 26(3):52-53. [2] DE LA PAZ COTA B R, CEPERO VEGA P P, MATUS NAVARRETE J J, et al. Efficacy and safety of eberconazole 1% otic solution compared to clotrimazole 1% solution in patients with otomycosis[J]. Am J Otolaryngol, 2018, 39(3):307-312. [3] 方秀玲,林功标,林伟,等. 103例外耳道真菌病的诊疗分析[J].中华耳科学杂志, 2019, 17(5):727-31. [4] 特比萘芬临床应用专家共识工作组.特比萘芬临床应用专家共识[J].中国真菌学杂志, 2020, 15(5):257-261. [5] CLSI. Performance standards for antifungal susceptibility testing of yeasts. M60[S]. Wayne,PA:Clinical and Laboratory Standards Institute,2017. [6] CLSI. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard.CLSI document M38-A2[S]. Wayne,PA:Clinical and Laboratory Standards Institute,2017. [7] 孟昭君,牛春生,刘春苗. 200例外耳道炎病原菌的培养与耐药性分析[J].中国耳鼻咽喉头颈外科, 2019, 26(3):52-53. [8] 谢琼,张先群,佘腊枝.兰美抒乳膏治疗外耳道真菌病120例[J].山东大学耳鼻喉眼学报, 2009,23(3):38. [9] 张祥宝,胡宝华.外耳道注入派瑞松软膏治疗真菌性外耳道炎疗效观察[J].中国中西医结合耳鼻咽喉科杂志, 2017,25(1):26-29. [10] SZIGETI G, KOCSUBÉ S, DÓCZI I, et al. Molecular identification and antifungal susceptibilities of black Aspergillus isolates from otomycosis cases in Hungary[J].Mycopathologia, 2012, 174(2):143-147. [11] SZIGETI G, SEDAGHATI E, MAHMOUDABADI A Z,et al. Species assignment and antifungal susceptibilities of black aspergilli recovered from otomycosis cases in Iran[J].Mycoses, 2012, 55(4):333-338. [12] 李永奇,何理风.耳内镜下抗真菌药局部注入治疗真菌性外耳道炎[J].中国临床研究, 2020, 33(1):94-97. |